CAMBRIDGE, Mass., Jan. 18 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals
Incorporated (Nasdaq: VRTX) will announce its fourth quarter and full year
2005 financial results on Tuesday, February 7, 2006 after the financial
markets close. The Company will host a conference call at 4:30 p.m. EST. The
conference call also will be webcast.
The live webcast will be available to all interested parties through
Vertex's website, http://www.vrtx.com, and will be archived on the Company's
website until February 21, 2006. To access the webcast, go to the investor
center and select 'conference calls.' To ensure a timely connection, it is
recommended that users register at least 15 minutes prior to the scheduled
webcast.
About Vertex
Vertex Pharmaceuticals Incorporated is a global biotechnology company
committed to the discovery and development of breakthrough small molecule
drugs for serious diseases. The Company's strategy is to commercialize its
products both independently and in collaboration with major pharmaceutical
companies. Vertex's product pipeline is principally focused on viral
diseases, inflammation, autoimmune diseases and cancer. Vertex co-promotes
the HIV protease inhibitor, Lexiva, with GlaxoSmithKline.
Lexiva is a registered trademark of the GlaxoSmithKline group of
companies.
Vertex's press releases are available at http://www.vrtx.com.
Vertex Contact:
Lora Pike, Manager, Investor Relations, (617)-444-6755
SOURCE Vertex Pharmaceuticals Incorporated
 back to top
Related links:
http://www.vrtx.com
Company News On-Call:
http://www.prnewswire.com/comp/938395.html
CONTACT:
Lora Pike, Manager of Investor Relations at
Vertex Pharmaceuticals Incorporated, +1-617-444-6755
|
